De novo 2p16.1 microdeletion with metastatic esophageal adenocarcinoma.
Don Chamil CodipillyRalitza H GavrilovaEric G TangalosPublished in: BMJ case reports (2017)
Microdeletions involving chromosome 2p15-16.1 are a rare genetic abnormality and have been reported in 18 separate patients, mainly children, since 2007. This microdeletion syndrome is characterised by a heterogeneous expression of intellectual impairment, dysmorphic facies, musculoskeletal abnormalities and potential neurodevelopmental anomalies. We report the first case of natural progression in an adult patient who died at a young age of metastatic esophageal adenocarcinoma. Important learning points include the variable phenotypic expression of this microdeletion syndrome and the fact that clinicians must be thorough in investigating objective discrepancies in patients who cannot endorse classical symptoms.
Keyphrases
- squamous cell carcinoma
- poor prognosis
- case report
- end stage renal disease
- small cell lung cancer
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- locally advanced
- prognostic factors
- binding protein
- gene expression
- genome wide
- physical activity
- patient reported outcomes
- rectal cancer
- human health